Amplify Weight Loss Drug & Treatment ETF (THNR) Investment Research Dashboard
About Amplify Weight Loss Drug & Treatment ETF (THNR) stock analysis
Get live THNR stock price $25.77, comprehensive Amplify Weight Loss Drug & Treatment ETF stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time THNR stock data and investment insights.
Loading chart data...
Amplify Weight Loss Drug & Treatment ETF (THNR) Overview
Amplify Weight Loss Drug & Treatment ETF (THNR) is a publicly traded company in the Financial Services sector , specifically within the Asset Management industry . As of the latest trading session, THNR trades at $25.77 with a market capitalization of 3.35M . Over the past 52 weeks, THNR has traded between $21.70 and $27.28 , with the current price positioned at approximately 73% of this range ...
Key Takeaways
- Operates in the Financial Services sector (Asset Management)
- Market cap: 3.35M
- Current price: $25.77
- 52-week range: $21.70 - $27.28
- P/E ratio: 20.84
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performan...
Company Information
- CEO
- Sector
- Financial Services
- Industry
- Asset Management
- Employees
- N/A
Contact Information
- Website
- https://amplifyetfs.com/thnr
- Address
- 3333 Warrenville Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 20.8)
✓ Lower volatility stock (Beta: 0.38) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Amplify Weight Loss Drug & Treatment ETF shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for Amplify Weight Loss Drug & Treatment ETF
- ⚠Investors should consider how Amplify Weight Loss Drug & Treatment ETF fits within their overall portfolio allocation
Market Cap
3.35M
P/E Ratio (TTM)
20.84
Beta
0.38
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare THNR with peer companies:
- Price
- $38.15-0.27% (1D)
- Market cap
- 3.09M
- Price
- $24.66-1.40% (1D)
- Market cap
- 3.02M
- Price
- $19.74+0.00% (1D)
- Market cap
- 2.86M
- Price
- $27.44-0.92% (1D)
- Market cap
- 2.64M
- Price
- $24.42+0.00% (1D)
- Market cap
- 2.45M
- Price
- $27.20+0.00% (1D)
- Market cap
- 2.77M
- Price
- $13.25-0.57% (1D)
- Market cap
- 3.32M
- Price
- $46.09-0.32% (1D)
- Market cap
- 3.36M
- Price
- $27.16+0.42% (1D)
- Market cap
- 2.73M
- Price
- $40.05-0.38% (1D)
- Market cap
- 2.96M
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.
Financial Services (1D)
98/100 ⭐⭐⭐⭐⭐
- Overall
- -0.4%
- NYSE
- -0.4%
- NASDAQ
- -0.3%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | -0.4% | +3.0% | +3.4% | 19.0 | 98/100⭐⭐⭐⭐⭐ |
| Communication Services | +0.4% | +1.9% | +3.3% | 22.3 | 86/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | +0.5% | +2.4% | +2.0% | 29.9 | 72/100⭐⭐⭐⭐⭐ |
| Healthcare | -0.8% | +1.8% | +1.9% | 23.9 | 68/100⭐⭐⭐⭐ |
| Basic Materials | -1.1% | -0.4% | -1.8% | 24.9 | 58/100⭐⭐⭐⭐ |
| Energy | -0.4% | -4.2% | -3.5% | 19.4 | 47/100⭐⭐⭐ |
| Real Estate | -1.6% | -1.2% | -2.6% | 28.7 | 44/100⭐⭐⭐ |
| Consumer Cyclical | -0.3% | -1.1% | -7.0% | 41.9 | 33/100⭐⭐ |
| Utilities | -2.7% | -4.7% | -7.5% | 25.9 | 22/100⭐ |
| Industrials | -2.6% | -1.6% | -14.0% | 29.0 | 14/100⭐ |
| Technology | -2.5% | -5.3% | -12.4% | 39.8 | 8/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-30.